233 related articles for article (PubMed ID: 33188723)
1. Plasma levels of S100A8/A9, histone/DNA complexes, and cell-free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura.
Sui J; Lu R; Halkidis K; Kocher NK; Cao W; Marques MB; Zheng XL
J Thromb Haemost; 2021 Feb; 19(2):370-379. PubMed ID: 33188723
[TBL] [Abstract][Full Text] [Related]
2. Identification of Biomarkers in Patients with Thrombotic Thrombocytopenic Purpura Presenting with Large and Small Ischemic Stroke.
Lin C; Memon R; Sui J; Zheng XL
Cerebrovasc Dis Extra; 2021; 11(1):29-36. PubMed ID: 33601375
[TBL] [Abstract][Full Text] [Related]
3. Anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura do not hamper ELISA-based quantification of ADAMTS13 antigen.
Dekimpe C; Roose E; Tersteeg C; Joly BS; Dewaele A; Horta S; Pareyn I; Vandenbulcke A; Deckmyn H; Feys HB; Tellier E; Kaplanski G; Scully M; Coppo P; De Meyer SF; Veyradier A; Vanhoorelbeke K
J Thromb Haemost; 2020 Apr; 18(4):985-990. PubMed ID: 31989742
[TBL] [Abstract][Full Text] [Related]
4. Plasma S100A8/A9 correlates with blood neutrophil counts, traditional risk factors, and cardiovascular disease in middle-aged healthy individuals.
Cotoi OS; Dunér P; Ko N; Hedblad B; Nilsson J; Björkbacka H; Schiopu A
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):202-10. PubMed ID: 24202303
[TBL] [Abstract][Full Text] [Related]
5. Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer.
Ronchetti L; Terrenato I; Ferretti M; Corrado G; Goeman F; Donzelli S; Mandoj C; Merola R; Zampa A; Carosi M; Blandino G; Conti L; Lobascio AM; Iacobelli M; Vizza E; Piaggio G; Gurtner A
J Exp Clin Cancer Res; 2022 Apr; 41(1):151. PubMed ID: 35449078
[TBL] [Abstract][Full Text] [Related]
6. Elevated plasma levels of syndecan-1 and soluble thrombomodulin predict adverse outcomes in thrombotic thrombocytopenic purpura.
Lu R; Sui J; Zheng XL
Blood Adv; 2020 Nov; 4(21):5378-5388. PubMed ID: 33141886
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies enhance ADAMTS-13 clearance in patients with immune thrombotic thrombocytopenic purpura.
Underwood MI; Alwan F; Thomas MR; Scully MA; Crawley JTB
J Thromb Haemost; 2023 Jun; 21(6):1544-1552. PubMed ID: 36813118
[TBL] [Abstract][Full Text] [Related]
8. Plasma S100A8/A9 Concentrations and Clinical Outcomes of Ischemic Stroke in 2 Independent Multicenter Cohorts.
Guo D; Zhu Z; Xu T; Zhong C; Wang A; Xie X; Peng Y; Peng H; Li Q; Ju Z; Geng D; Chen J; Liu L; Wang Y; Zhang Y; He J
Clin Chem; 2020 May; 66(5):706-717. PubMed ID: 32285094
[TBL] [Abstract][Full Text] [Related]
9. Management of immune thrombotic thrombocytopenic purpura with caplacizumab: a Canadian, single-centre, real-world experience.
Tse B; Buchholz M; Pavenski K
Platelets; 2023 Dec; 34(1):2157807. PubMed ID: 36636834
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura.
Sui J; Cao W; Halkidis K; Abdelgawwad MS; Kocher NK; Guillory B; Williams LA; Gangaraju R; Marques MB; Zheng XL
Blood Adv; 2019 Dec; 3(24):4177-4186. PubMed ID: 31856267
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report.
Schwaegermann MK; Hobohm L; Rausch J; Reuter M; Griemert TF; Sivanathan V; Falter T; Sprinzl MF; Lackner KJ; Galle PR; Konstantinides S; Theobald M; von Auer C
Hamostaseologie; 2023 Jun; 43(3):215-218. PubMed ID: 34327693
[TBL] [Abstract][Full Text] [Related]
12. Circulating S100A8/A9 Levels Reflect Intraocular Inflammation in Uveitis Patients.
Wang YQ; Dai XD; Ran Y; Cao Y; Lan CL; Guan JT; Liu C; Yang FM; Gan YJ; Liu BJ; Fang AW; Lin D; Gong XH; Cui RZ; Jin ZB; Qu J; Lu F; Chi ZL
Ocul Immunol Inflamm; 2020; 28(1):133-141. PubMed ID: 30395736
[No Abstract] [Full Text] [Related]
13. Elevation of inflammatory S100A8/S100A9 complexes in intracranial aneurysms.
de Korte AM; Aquarius R; Vogl T; Roth J; Bartels RHMA; Boogaarts HD; van Lent PLEM; De Vries J
J Neurointerv Surg; 2020 Nov; 12(11):1117-1121. PubMed ID: 32332055
[TBL] [Abstract][Full Text] [Related]
14. Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura.
Pascual-Izquierdo C; Del Rio-Garma J; de la Rubia J; Viejo A; Mingot E; Cid J; Solanich X; Fernández-Sojo J; Martín-Sánchez J; Hernández L; García-Gala JM; Alonso N; González V; Oliva A; Gómez-Seguí I; Goterris R; Guerra L; García-Candel F; Fernández-Docampo M; Antelo ML; Salgado-Barreira Á; Salinas R;
J Clin Apher; 2021 Aug; 36(4):563-573. PubMed ID: 33780553
[TBL] [Abstract][Full Text] [Related]
15. Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma.
Şumnu Ş; Mehtap Ö; Mersin S; Toptaş T; Görür G; Gedük A; Ünal S; Polat MG; Aygün K; Yenihayat EM; Albayrak H; Uluköylü Mengüç M; Tarkun P; Hacıhanifioğlu A
Int J Lab Hematol; 2021 Aug; 43(4):638-644. PubMed ID: 33904653
[TBL] [Abstract][Full Text] [Related]
16. The Association Between S100A8/A9 and the Development of Very Late Stent Thrombosis in Patients With Acute Myocardial Infarction.
Wang X; Guan M; Zhang X; Ma T; Wu M; Li Y; Chen X; Zheng Y
Clin Appl Thromb Hemost; 2020; 26():1076029620943295. PubMed ID: 32734774
[TBL] [Abstract][Full Text] [Related]
17. Exome Sequencing Identifies Abnormalities in Glycosylation and ANKRD36C in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura.
Basu MK; Massicano F; Yu L; Halkidis K; Pillai V; Cao W; Zheng L; Zheng XL
Thromb Haemost; 2021 Apr; 121(4):506-517. PubMed ID: 33184803
[TBL] [Abstract][Full Text] [Related]
18. Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura.
Roose E; Schelpe AS; Tellier E; Sinkovits G; Joly BS; Dekimpe C; Kaplanski G; Le Besnerais M; Mancini I; Falter T; Von Auer C; Feys HB; Reti M; Rossmann H; Vandenbulcke A; Pareyn I; Voorberg J; Greinacher A; Benhamou Y; Deckmyn H; Fijnheer R; Prohászka Z; Peyvandi F; Lämmle B; Coppo P; De Meyer SF; Veyradier A; Vanhoorelbeke K
Blood; 2020 Jul; 136(3):353-361. PubMed ID: 32356859
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of interleukins and S100A8/A9 correlate with clinical severity in patients with dermatomyositis-associated interstitial lung disease.
Lou Y; Zheng Y; Fan B; Zhang L; Zhu F; Wang X; Chen Z; Tan X; Wei Q
BMC Pulm Med; 2020 Jul; 20(1):196. PubMed ID: 32680574
[TBL] [Abstract][Full Text] [Related]
20. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.
Tydén H; Lood C; Gullstrand B; Jönsen A; Ivars F; Leanderson T; Bengtsson AA
Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
